Research also
continues funded by MD Anderson's Melanoma Moon Shot ™.
This program is contingent upon
continued funding by the Vermont legislature to the Vermont Agency of Agriculture and we hope that the legislature will continue funding in 2018.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to
continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment
by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders
by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional
funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending
by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to
continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
There are and will
continue to be death kick strategies and tell - tale signs of life; smaller more narrowly focused
funds, deal -
by - deal
funds, and a focus on trendy categories like life sciences and alternative energy.
Its NRA card was also highlighted in a New York Times opinion piece that called on the financial industry to exert its «leverage over the gun industry,» seeing as politicians — many of whom are
funded by the NRA —
continue to refrain from doing so.
«Beginning in November 2014 and
continuing until his arrest in March 2016, CASPERSEN engaged in a Ponzi - like scheme to defraud investors, including his close friends, family members, and college classmates,
by falsely claiming that their
funds would be used to make secured loans to private equity firms and would thereby earn an annual rate of return of 15 to 20 percent.
«Goldilocks Investment Company Ltd has filed legal action today in light of the
continuing refusal
by Noble Group Ltd to recognize legitimate legal rights of Goldilocks as a shareholder of Noble,» the investment
fund, which holds an 8.1 percent stake in Singapore - listed Noble said in a statement.
The Turkish government remains committed to
continue supporting entrepreneurship as evidenced
by their plans to form a new venture - capital
fund of
funds to provide additional capital to early - stage companies.
Amazon.com founder Jeff Bezos» Blue Origin company in Washington state received NASA
funding in the early rounds of competition, then said it would
continue working on its own, unfunded
by the government.
The $ 3 trillion hedge
fund industry, which has been struggling to outperform stock and bond markets, could see assets shrink
by as much as 30 percent in the next three years if performance
continues to disappoint, according to a report this month from Boston Consulting Group.
Camden Fine told CNBC that comments
by JP Morgan CEO Jamie Dimon on the economy and regulation «reflect Wall Street's inability to take responsibility for the economic crisis it caused and the taxpayer -
funded guarantee against failure it
continues to enjoy....
That assumes
continued share buybacks,
funded from an estimated operating cash flow of over $ 25 billion a year
by 2018.
* On Monday, prices tumbled sharply before paring losses as technical trading
by funds continued to drive activity in the market.
It didn't work, as Chinese equity markets
continued their descent on Monday, fueling worry because it is unclear how much of the country's bull market was
funded by individuals borrowing to buy stocks.
And that is a trend that keeps snowballing, thanks primarily to the activities of two groups: first, the pension
funds, insurers, and other large investors that
continue to accelerate their investments in growth companies; and second, the investment - world professionals, who are responding to the deluge of money
by continually setting up new
funds.
And Ring's hot streak
continues: On Wednesday, Ring announced it raised $ 61.2 million in
funding from a group of investors led
by the venture - capital firm Kleiner, Perkins, Caufield and Byers, bringing in one of the most successful Silicon Valley VC firms as an investor.
Newspapers are finding that paywalls may not be a long - term strategy (which doesn't seem to have stopped magazine publishers like Time Inc., which owns Fortune, from
continuing to try), and so they either have to go broad and mass like The Daily Mail or find another monetization strategy like The Guardian, which has a trust
fund that was generated
by selling its stake in Auto Trader for $ 1 billion or so.
Looking at the global economy, the
Fund noted that «global economic activity
continues to firm up» and is estimated to have grown
by 3.7 percent in 2017, which is 0.1 percentage points faster than projected in the fall.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or
continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of
funding for state AIDS Drug Assistance Programs (ADAPs);
continued fluctuations in ADAP purchases driven
by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused
by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held
by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
The money was «paid
by his lawyer the way I would do it,» he
continued, «out of his law firm
funds or whatever
funds, it doesn't matter, and the president reimbursed that over a period of several months.»
An inactive market may also impair our ability to raise capital to
continue to
fund operations
by selling shares and may impair our ability to acquire other companies or technologies
by using our shares as consideration.
The new
funding, led
by Goldman Sachs and Princeville Global (with participation from existing investors, including Venrock, Shasta Ventures and Tenaya Capital), will be used to
continue the company's rapid expansion in the U.S. and abroad — and brings the company's total financing to $ 160 million.
As the ecosystem around blockchain
continues to expand and develop, Ripple will look to support new use cases of the technology including more investments in business use cases developed
by entrepreneurial teams and
funds.
It is of great importance that the public is confident that the federal
funds rate will be, on average over time, within the target range set forth
by the FOMC, and that other money market rates will
continue to move closely with changes in the federal
funds rate.
The HFRI Indices are based on information self - reported
by hedge
fund managers that decide, on their own, at any time, whether or not they want to provide, or
continue to provide, information to HFR Asset Management, LLC (HFR).
In bonds, the Market Climate
continued to be characterized
by unfavorable valuations and unfavorable market action, holding the Strategic Total Return
Fund to a short 2 - year duration, mostly in Treasury inflation protected securities.
Indeed, in 2013, in response to
continued suggestions
by the media and governments that Bitcoin was playing a primary role in
funding terrorism, the UK parliament issued a report indicating that ISIS was not receiving any significant
funding through virtual currency:
We have navigated this through thoughtful portfolio construction, and will
continue to do so, specifically
by allocating to flexible mandate and absolute return mutual
funds.
By the end of that month, yields on the 10 - year Treasury note had climbed by nearly one - half of one percent — yet money continued to flow in to bond fund
By the end of that month, yields on the 10 - year Treasury note had climbed
by nearly one - half of one percent — yet money continued to flow in to bond fund
by nearly one - half of one percent — yet money
continued to flow in to bond
funds.
United States Solar Corporation («US Solar»), a leading community solar developer, announced today it has secured a project financing facility from the Alliance
Fund II, LP, an affiliate of North Sky Capital which is advised
by New Energy Capital Partners...
Continue reading →
«Despite the
continued support of attacks
by activist hedge
funds by the Chair of the SEC, and many «Chicago school» academics who
continue to rely on discredited statistics, there is growing recognition
by institutional investors and prominent «new school» economists of the threat to corporations and their shareholders and to the economy of these attacks -LSB-...]
Take advantage of the power of compounding in accruing your future retirement
funds by continuing to make disciplined contributions to qualified tax - advantaged vehicles.
As veteran Japan watcher Richard Werner (author of Princes of the Yen) recently described the situation to me, «while Japanese small firms were killed
by the
continued refusal of banks to expand credit (and many a small firm president was killed
by having to sell a kidney to the loan sharks he was forced to resort to), foreign speculators received ample yen
funds for a pittance.»
With more and more
funds flowing from mutual
funds to index
funds (because mutual
funds have consistently failed to outperform) the last thing they will want to see is their underperformance exacerbated
by remaining underweight Apple as it
continues to outperform.
Perkins Coie, at Elias's behest and with the bills ultimately paid
by Clinton and the DNC,
continued to
fund Fusion's work through the end of October 2016, though the people involved say that neither the campaign nor the DNC was aware of the details of Fusion's work.
The letter
continued: «Our ad reminds viewers that Kim Jong - un and his army of hackers have been stealing billions of dollars of Bitcoin and other digital currencies for the past few years,
funding their rogue nuclear weapons programs and thwarting efforts
by the rest of the world to sanction this behavior.»
The Tocqueville Select
Fund will
continue to be managed
by co-lead portfolio managers Mr. Delafield and Mr. Sellecchia alongside Donald Wang, who has worked on this strategy since 1999.
Interest rates have
continued to be pushed lower and lower and lower and most of this is because the Fed keeps on adjusting that federal
fund's rate and adjusting interest rates down in the way that they do that is
by putting cash into the market and buying back bonds or short - term bonds with the federal
fund's rate.
According to the Global Financial Stability Report released
by the IMF (International Monetary
Fund), a large number of US companies servicing their debt could be in trouble if the Fed
continues to raise rates.
Strategic Total Return
continues to carry a duration of about 3.5 years in Treasury securities (meaning that a 100 basis point move in interest rates would be expected to impact the
Fund by about 3.5 % on the basis of bond price fluctuations), and holds about 10 % of assets in precious metals shares, and about 5 % of assets in utility shares.
While the two largest Spanish banks — BBVA and Santander — have
continued to grow, albeit driven
by profitable Latin American operations, small regional savings bank have been struggling in a market characterized
by slow economic growth, higher
funding costs and unemployment near 21 %.
Presentations on topics such as (a) the relationships among price movements of stock indexes, the CBOE Volatility Index ® (VIX ®), and the India VIX Index, and (b) new studies on
fund use of options and volatility - based strategies, will be delivered
by me to
continuing - education meetings of the Indian Association of Investment Professionals (IAIP) in the cities -LSB-...]
While the Strategic Growth
Fund does have enough call options presently to reduce our hedge
by about 40 % in the event of a substantial
continued advance (they currently provide us with a 10 - 15 % exposure to market fluctuations), that position still amounts to only about 1 % of assets.
All that work is proceeding as Spectra
continues to investigate the feasibility of its proposed Fort Nelson project - a study that is being
funded, in part,
by a $ 3.4 million grant from the province.
Given that the Market Climate in bonds
continues to be characterized
by unfavorable valuations and unfavorable market action, the Strategic Total Return
Fund continues to carry a muted duration of about 2 years, mostly in Treasury Inflation Protected Securities.
Against this backdrop, the Federal Reserve has
continued the process of normalising interest rates, lifting the federal
funds rate
by 25 basis points at each of its last six meetings, to 2.5 per cent in February.
By continuing along its current course (which involves MBS purchases and keeping the
funds rate near zero), the Federal Reserve is having an indirect effect on long - term mortgage rates.
Judging
by the
continued flow of assets into passive index
funds and ETFs, investors remain unfazed
by these concerns.
As employers
continue to shift benefit choices and the
funding of those benefits onto employees, Unum is keeping pace
by investing in its product portfolio, distribution and enrollment platforms, executives said.
We are confident that this latest placement
by Alberta Enterprise in Yaletown Innovation Growth
Fund will
continue to develop valuable connections and investment channels for Alberta companies,» said Kristina Williams, CEO, Alberta Enterprise Corporation.